Beyond the Flush:
ALDH2*2: “THE MOST COMMON SINGLE-POINT MUTATION IN HUMANS.”
The strongest established disease association.
For people with ALDH2 Deficiency, drinking alcohol results in greater exposure to acetaldehyde, a Group 1 human carcinogen. Research cited by Young and Seung reports progressively higher odds of esophageal cancer with increasing alcohol consumption, with the greatest danger among heavy drinkers who also smoke.
An emerging association requiring further research.
ALDH2 normally helps clear toxic aldehydes produced by oxidative stress. Research sited by Young and Seung associates impaired ALDH2 activity with increased oxidative stress, mitochondrial dysfunction, and amyloid-B accumulation—processes involved in Alzheimer’s disease.
ALDH2 Deficiency has been associated with several cardiovascular risks.
Research summarized by Young and Seung links impaired ALDH2 activity with hypertension, myocardial infarction (heart attack), and ischemic stroke. ALDH2 also participates in the bioactivation of nitroglycerin; reduced ALDH2 activity may therefore diminish the medication’s effectiveness.
Direct, sustained engagement with community members affected by the ALDH2*2 variant.
East Asian Americans have little to no awareness.
Collaboration between community members, researchers, & healthcare systems to build trust, ensure cultural relevance, promote awareness, & integrate genetic testing.
Invest in therapeutic interventions.
Develop preventive strategies for reducing alcohol-associated cancers, cardiovascular, & neurodegenerative disease risks in individuals with ALDH2 deficiency.
National & international medical organizations should incorporate ALDH2 genotyping into evidence-based practice guidelines.
Provide clinicians with recommendations for screening, risk stratification, counseling, & management of patients carrying the ALDH2*2 variant.
Ensure ALDH2 genetic screening is accessible & delivered through a health equity lens.
Screening programs should include culturally tailored education, community outreach, & inclusive policies that promote equitable access to testing & follow-up healthcare.
Alcohol consumption dramatically heightens risk through Group 1 carcinogen (acetaldehyde) accumulation.
Emerging link: ALDH2 is neuroprotective.
Deficiency leads to oxidative stress and amyloid-β accumulation.
Elevated risks of hypertension, myocardial infarction, and ischemic stroke.
Interferes with metabolism of crucial drugs (e.g., nitroglycerin).
Source: Young JL, Seung F. “Beyond the Flush: Reframing ALDH2 Deficiency as a Public Health Risk.” Public Health Genomics. 2026; DOI: 10.1159/000549941. Educational summary and infographic interpretation by ALDH2Deficiency.com.
A person inherits one ALDH2 gene copy from each parent. A person may inherit one ALDH2*2 variant copy (ALDH2*1/2; heterozygous) or two ALDH2*2 variant copies (ALDH2*2/2; homozygous).
The rs671 variant produces the ALDH2*2 form of the gene and substantially reduces ALDH2 enzyme activity, impairing the body’s ability to rapidly convert toxic acetaldehyde into acetate. One variant copy substantially reduces activity; two variant copies result in very little functional ALDH2 activity.
When endogenous glutathione is used in aldehyde detoxification and antioxidant defense, cellular glutathione reserves can become depleted.
An imbalance between ROS and antioxidants causes cellular damage and disrupts normal cellular function.
Oxidation can damage DNA and interfere with normal repair processes.
Oxidation of cell membranes affects fluidity, integrity and signaling.
Oxidative modifications can alter protein structure and function.
Impaired energy production and increased oxidative damage.
It participates in normal antioxidant defense, cellular metabolism and detoxification processes.
